General Information of Drug (ID:
DR2473) |
Drug Name |
Nafronyl oxalate
|
Synonyms |
Nafronyl oxalate; Nafronyl oxalate salt; Naftidrofuryl (oxalate); Naftidrofuryl oxalate; Praxilene; Dubimax; Dusodril; EU-1806; Iridus; LS 121; LS-121; naftidrofuryl hydrogen oxalate; 2-(Diethylamino)ethyl 3-(naphthalen-1-yl)-2-((tetrahydrofuran-2-yl)methyl)propanoate oxalate; CAS-3200-06-4; CHEMBL1439099; DSSTox_CID_25533; DSSTox_GSID_45533; DSSTox_RID_80935; NSC225233; Nafronyl oxalate salt, analytical standard; SMR000539007; alpha-[1-Naphthylmethyl]-2-tetrahydrofuranpropionic acid diethylaminoethyl ester
|
Indication |
Arteriosclerosis obliterans
[ICD11: BD40]
|
Phase 4
|
[1]
|
Structure |
|
|
3D MOL is unavailable
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
473.6 |
Topological Polar Surface Area |
113 |
Heavy Atom Count |
34 |
Rotatable Bond Count |
12 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
8 |
Cross-matching ID |
- PubChem CID
- 312915
- CAS Number
-
- TTD Drug ID
- D07YWY
- Formula
- C26H35NO7
- Canonical SMILES
- CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32.C(=O)(C(=O)O)O
- InChI
- 1S/C24H33NO3/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3
- InChIKey
- SSAJNPNVUYMUCI-UHFFFAOYSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.